JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.59% |
| 2 | Technology | 12.2% |
| 3 | Healthcare | 9.44% |
| 4 | Consumer Discretionary | 8.6% |
| 5 | Industrials | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRCI
651
DELISTED
SRC Energy Inc
SRCI
| $99.3M | 0.02% |
11,646,441
-217,643
| -2% | -$1.92M |
|
652
Baker Hughes
BKR
$61.1B
| $98.9M | 0.02% |
3,125,835
+297,697
| +11% | +$9.55M |
|
653
Bright Horizons
BFAM
$3.86B
| $98.7M | 0.02% |
1,049,749
+47,431
| +5% | +$4.2M |
|
654
Pilgrim's Pride
PPC
$6.54B
| $98.7M | 0.02% |
3,176,210
-976,115
| -24% | -$31.9M |
|
655
Gartner
IT
$11.7B
| $98.4M | 0.02% |
798,753
-320,297
| -29% | -$38.9M |
|
656
Valvoline
VVV
$4.51B
| $98.1M | 0.02% |
3,914,905
+336,923
| +9% | +$8.14M |
|
|
GWB
657
DELISTED
Great Western Bancorp, Inc.
GWB
| $98M | 0.02% |
2,462,110
+25,774
| +1% | +$1.04M |
|
|
EQM
658
DELISTED
EQM Midstream Partners, LP
EQM
| $97.9M | 0.02% |
1,339,462
+67,545
| +5% | +$4.83M |
|
659
General Mills
GIS
$19.7B
| $97.9M | 0.02% |
1,651,069
+956,740
| +138% | +$51.7M |
|
|
EV
660
DELISTED
Eaton Vance Corp.
EV
| $97.4M | 0.02% |
1,727,560
-41,436
| -2% | -$2.19M |
|
661
Ventas
VTR
$47.9B
| $97.3M | 0.02% |
1,620,631
-1,551,773
| -49% | -$98.1M |
|
|
VER
662
DELISTED
VEREIT, Inc.
VER
| $97.2M | 0.02% |
2,494,764
+1,769,577
| +244% | +$71M |
|
663
Dominion Energy
D
$59.3B
| $96.9M | 0.02% |
1,195,963
+597,309
| +100% | +$48.4M |
|
|
GCP
664
DELISTED
GCP Applied Technologies Inc.
GCP
| $96.7M | 0.02% |
3,031,231
+62,423
| +2% | +$1.92M |
|
|
COL
665
DELISTED
Rockwell Collins
COL
| $96.6M | 0.02% |
712,495
-212,254
| -23% | -$28.4M |
|
666
CALL
Wells Fargo
WFC
$264B
| $96.6M | 0.02% |
1,592,700
+1,321,000
| +486% | +$74.6M |
|
|
BGC
667
DELISTED
General Cable Corporation
BGC
| $96.6M | 0.02% |
3,262,026
+1,250,608
| +62% | +$29.6M |
|
668
COPT Defense Properties
CDP
$4.21B
| $96.5M | 0.02% |
3,306,281
+172,593
| +6% | +$5.41M |
|
669
Stellantis
STLA
$20.8B
| $96.5M | 0.02% |
5,408,546
-2,112,414
| -28% | -$37.2M |
|
670
Lockheed Martin
LMT
$136B
| $96.4M | 0.02% |
300,365
+128,727
| +75% | +$40.6M |
|
671
Quaker Houghton
KWR
$2.92B
| $96.2M | 0.02% |
638,094
+21
| +0% | +$3.25K |
|
672
PG&E
PCG
$38.5B
| $95.9M | 0.02% |
2,139,850
-2,129,525
| -50% | -$119M |
|
673
Nektar Therapeutics
NKTR
$2.58B
| $95.9M | 0.02% |
107,058
-47,898
| -31% | -$28.3M |
|
674
ICU Medical
ICUI
$4.61B
| $95.7M | 0.02% |
443,011
+10,730
| +2% | +$2.17M |
|
675
Western Alliance Bancorporation
WAL
$8.87B
| $95.6M | 0.02% |
1,689,175
-211,084
| -11% | -$11.8M |
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 811 new, 2,514 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 811 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.